Wockhardt is one of the top global pharmaceutical and biotechnology companies. It has market capitalization of about US $1 billion and annual turnover of about US $400 million. Europe and
US pharma markets account for about 50% of Wockhardt’s revenue.
Wockhardt has six dedicated manufacturing plants built in accordance with international standards. It has a competent, multi-disciplinary research team of over 450 skilled scientists. It owns 6 breakthrough biotechnology products and more than 250 patent filings. It has a strong presence in international pharmaceutical market. Its product portfolio comprises of biopharmaceuticals, formulations, vaccines, nutrition products, and active pharmaceuticals ingredients (API).
Its products include:
- Topicals (Creams and Ointments)
- Steriles (Injectables)
- Orals (Tablets and Liquids)
Wockhardt has headquarters in India and three subsidiaries in UK, US and Ireland. It possesses 11 manufacturing plants in 3 countries viz. India, Ireland and UK. The four successful acquisitions done by Wockhardt in the European market have strengthened the global position of
Bandra (East), Mumbai – 400 051,
Tel.: + 91 – 22 – 26534444
Fax: + 91 – 22 – 26534242
Quarterly Results of Wockhardt
|Dec 2006(3 rd quarter)||Sept 2006(2nd quarter)||Dec 2005(3 rd quarter)|
|% Change (Over Sep 2006)||% Change (Over Dec 2005)|
Annual Results of Wockhardt
|(12 Months)||(12 Months)||% Changes|